Preliminary evaluation of the performance of a new highly sensitive commercial immunoassay for serum ferritin determination by P. Sign\uf2 et al.
Clin Chem Lab Med 2005;43(8):883–885  2005 by Walter de Gruyter • Berlin • New York. DOI 10.1515/CCLM.2005.149
Article in press - uncorrected proof
Short Communication
Preliminary evaluation of the performance of a new, highly
sensitive commercial immunoassay for serum ferritin
determination
Paolo Signo`1, Alessandra Barassi2,*, Raffaele
Novario3 and Gian Vico Melzi d’Eril4
1 Laboratorio di Analisi, Ospedale di Circolo, Varese,
Italy
2 Dipartimento di Scienze Biomediche Sperimentali e
Cliniche, Universita` degli Studi dell’Insubria, Varese,
Italy
3 Fisica Sanitaria, Ospedale di Circolo, Varese, Italy
4 Dipartimento di Medicina, Chirurgia e Odontoiatria,
Universita` degli Studi di Milano, Milano, Italy
Abstract
We evaluated the analytical performance of a new,
commercial, fully automated immunoturbidimetric
assay for the determination of ferritin wFER-
Latex(X2)CN SEIKEN, Denka Seiken, Japanx in serum
on the Olympus AU2700 analyzer. The new assay is
a latex-enhanced turbidimetric immunoassay with an
analysis time of 10 min. The linearity of the assay was
confirmed up to 2505 pmol/L (R2s0.999). The detec-
tion limit and the functional sensitivity were both
4.5 pmol/L. The intra- and inter-assay imprecision
(CV) at 67, 506, 2186 pmol/L was -1.8% and -2.5%,
respectively. Verification of the traceability to a WHO
standard (80/578) showed a recovery of 102.6% (tar-
get value 449 pmol/L). No hook effect was observed
in samples containing up to 33,705 pmol/L. The assay
showed good correlation with the Beckman Immage
nephelometric system (rs0.999). Hemoglobin
(F9.8 g/L), total bilirubin (F113 mmol/L), conjugated
bilirubin (F109 mmol/L) and rheumatoid factor
(F5.2=105 IU/L) did not interfere with the assay. The
reference interval (2.5–97.5 percentile) was 72–521
pmol/L for men and 27–267 pmol/L for women. The
reference interval in patients with anemia, malignant
tumors and hemochromatosis was 5.6–52, 130–2436
and 1465–2903 pmol/L, respectively. On the basis of
the receiver operating characteristic curve, the 90%
sensitivity cut-off value to distinguish between
patients with and without iron deficiency was
40 pmol/L. The new latex turbidimetric procedure for
ferritin assay is an attractive alternative that avoids
the need for dedicated instrumentation.
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Ferritin is a large, multifunctional, multisubunit pro-
tein that plays an important role in iron storage and
metabolism. Its ability to sequester the element gives
ferritin the double function of iron detoxification and
reserve (1). Ferritin assays must have a broad dyna-
mic range, as the serum concentrations can vary from
)2247 pmol/L in some types of malignancies (2) to
-23 pmol/L in iron-deficiency anemia (3). The deter-
mination of serum ferritin can be useful in detecting
hemochromatosis in most subjects in a precirrhotic
stage without irreversible complications (4). Finally,
preliminary studies suggest that increased ferritin
might be an independent predictor of premature cor-
onary artery disease in male patients (5). Thus, pre-
cise measurement in the lower range is required for
the diagnosis of iron-deficiency anemia, while a wide
analytical range is useful for measurement in patients
with tumors, inflammation, hemochromatosis or
atherosclerosis.
The aim of this study was to evaluate a new serum
ferritin assay, FER-Latex(X2)CN SEIKEN (Denka Sei-
ken, Tokyo, Japan), on the Olympus AU 2700 analyzer
(Olympus Diagnostics GmbH, Hamburg, Germany) by
defining key performance characteristics, including
detection limit, linearity on dilution, recovery, impre-
cision, comparison with a nephelometric method
(Beckman Immage Assay, Beckman-Coulter, Fuller-
ton, CA, USA), reference interval and cut-off value for
iron-deficiency anemia. The method chosen for com-
parison is a well-established and widespread system
for ferritin determination and the standards were cali-
brated against the 80/578 WHO Reference Prepara-
tion. The new assay is a latex-enhanced turbidimetric
immunoassay that uses six different calibrators. Cali-
brator A is a 10 mmol/L HEPES buffer (pH 7.5). Cali-
brators B–F contain increasing concentrations of
ferritin (67, 225, 450, 1124 and 2247 pmol/L) in HEPES
buffer. These calibrators are traceable to the WHO
standard (80/602).
The new FER-Latex method on the Olympus ana-
lyzer requires 15 mL of sample, 180 mL of Reagent 1
(170 mmol/L glycine buffer, pH 8.3) and 80 mL of Re-
agent 2. Reagent 2 consists of a suspension of poly-
styrene latex particles in 170 mmol/L glycine buffer
(pH 7.3) coated with anti-human ferritin polyclonal
antibodies. The latex particles are agglutinated
according to the ferritin dose, which causes increased
turbidity that is detected at 660 nm, with a total ana-
lysis time of 10 min. For comparison, the Beckman
Immage assay was performed according to the manu-
facturer’s recommendations.
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Figure 1 Functional sensitivity (A) defined as the lowest
measurable ferritin concentration with a CV of -20%. Com-
parison of the FER-Latex(X2)CN SEIKEN assay with the Beck-
man Immage assay (B) according to Passing-Bablok
regression analysis. The dashed line represents the equiva-
lence line.
We examined the linearity of the new method by
analyzing 10 protein concentrations. Fresh plasma
samples were used to prepare a high-concentration
patient plasma pool ()2247 pmol/L). The undiluted
pool and nine separate dilutions (9:1, 8:2, 7:3, 6:4, 5:5,
4:6, 3:7, 2:8, and 1:9) were assayed in duplicate in the
same analytical run. Linear regression analysis was
carried out and Pearson’s correlation coefficient was
calculated (ys0.988x–5.512; R2s0.999). The results
(percentage of theoretical concentrations) showed
values between 96.2% and 98.6%, with a median bias
of y2.8%; therefore, the method is linear within its
measurement range (2505 pmol/L was the mean of
the high-concentration pool). The standard error of
regression (Sy/x) and t-test for the regression analysis
were 3.082 and 343.4 (p-0.001), respectively. The
minimum detectable ferritin concentration was
assessed by 21 replicate measurements of the zero
calibrator in a single run and defined as the ferritin
value corresponding to a signal 2 SD greater than the
mean found for this sample. On the basis of this pro-
cedure, the detection limit was 4.5 pmol/L for the
assay. In addition, the functional sensitivity, defined
as the concentration with an inter-assay imprecision
(CV) -20%, was 4.5 pmol/L (Figure 1A). This coinci-
dence of the functional sensitivity with the detection
limit is probably a consequence of the reagents (buf-
fers), which are unaffected by the matrix. This study
was performed by preparing seven serial dilutions of
a ferritin pool, ranging from 1.1 to 23 pmol/L. To
determine between-run imprecision, three pooled
patient serum samples were aliquoted and frozen at
y208C. Two replicates/specimens were analyzed per
run and one run per day for 21 days, using two re-
agent lots and two calibrations. CVs calculated from
the means of each run were 2.5% (mean concentra-
tion 70 pmol/L), 1.5% (mean concentration 510
pmol/L) and 2.0% (mean concentration 2209 pmol/L).
Within-run CVs were 1.8% (mean concentration
67 pmol/L), 0.5% (mean concentration 497 pmol/L)
and 1.2% (mean concentration 2164 pmol/L). In this
study, 21 replicates were analyzed in duplicate in the
same analytical run.
The recovery of controls (Immuno-Q-sera II SEIKEN)
calculated by the difference between expected and
observed values (percentage recovery) was 98.1%
(ns15; target value 243 pmol/L, mean"SDs
238"4.3 pmol/L) and 99.3% (ns15; target value
944 pmol/L, mean"SDs937"9.7 pmol/L). Additional
recovery experiments using two different concentra-
tions of the calibrator in five samples gave a mean
recovery from ten measurements of 98.8% (range
97.3–101.5%) of the calculated value. Verification of
the traceability to the WHO standard, using the Beck-
man-Coulter Calibrator for ferritin (80/578 WHO stan-
dard), showed a recovery of 102.6% (ns15; target
value 449 pmol/L, mean"SDs461"4.0 pmol/L). To
determine whether highly increased concentrations of
ferritin cause a ‘‘hook effect’’, a high-concentration
serum pool was diluted with calibrator A. Final con-
centrations ranged from 2022 to 53,928 pmol/L and
the samples were analyzed in duplicate. The results
obtained from the undiluted samples were compared
with those obtained from the same samples diluted
to fall within the range of linearity. No hook effect was
observed in samples containing up to 33,705 pmol/L
of antigen, because the difference between the two
determinations was below 5%. Passing and Bablok
regression analysis (6) was used for method compar-
ison between the FER-Latex(X2)CN SEIKEN assay and
the Beckman Immage nephelometric system. To
avoid any dilution, we limited the range for this exper-
iment to the ranges reported for the two ferritin meth-
ods. For the comparison study, we used samples from
120 patients scheduled for ferritin determination for
diagnostic purposes and/or monitoring of medical
treatment. Passing and Bablok regression analysis
(Figure 1B) revealed an intercept of 15.3 pmol/L (95%
CI 13–20), a slope of 1.05 (95% CI 1.04–1.06), and a
coefficient of correlation (r) of 0.999, suggesting
that the values obtained with the new method are
slightly higher than those obtained with the compar-
ison assay. As a consequence the w(compared)–
(comparison)x mean differences at the lower and
higher reference limits for males and females (72, 27,
521 and 267 pmol/L) are 16, 17, 40 and 27 pmol/L,
respectively.
Using a pool of samples with a mean concentration
of 211 pmol/L of ferritin spiked with interferents and
processed in duplicate did not affect results signifi-
cantly, even though the concentrations of interferents
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in spiked samples were 113 mmol/L total bilirubin
(recovery 100.0%), 109 mmol/L conjugated bilirubin
(recovery 101.0%), 9.8 g/L hemoglobin (recovery
103.0%) and 5.2=105 IU/L rheumatoid factor (recovery
102.8%). The spiking solutions were prepared from
stock solutions containing known levels of interfe-
rents. Stored calibration curves were compared with
fresh calibration curves. Two levels of controls and
two human serum pools were analyzed at 1-week
intervals. The calibration curve is stable for at least
1 month (error -5%).
Four groups of subjects entered the clinical evalu-
ation study. Group 1 included 140 (70 males and 70
females; median age 39 years; range 21–53 years)
healthy individuals using exclusion criteria as sug-
gested in IFCC recommendations on the theory of ref-
erence values (7). The other three groups consisted of
80 iron-deficiency anemia patients, 80 subjects with a
malignant tumor and 25 hemochromatosis patients.
The three pathological groups were classified accord-
ing to the following criteria: transferrin saturation
-15% and hemoglobin -140 g/L in males or -120
g/L in females for iron-deficiency anemia patients; his-
tolopathological findings for subjects with a malig-
nant tumor; and homozygosity for the C282Y
mutation of the HFE gene for patients with hemo-
chromatosis. The procedures followed were in accor-
dance with the current revision of the Helsinki
Declaration (8). The reference interval for ferritin cal-
culated by non-parametric determination of 2.5–97.5
percentiles was 72–521 pmol/L for men and
27–267 pmol/L for women. The reference interval in
patients with anemia, malignant tumors and hemo-
chromatosis was 5.6–52, 130–2436 and 1465–2903
pmol/L, respectively.
To determine the diagnostic accuracy of the assay
for anemia, we performed receiver operating charac-
teristic (ROC) plot analysis, and the area under the
curve (AUC) was calculated. The cut-off value was
determined at the 90% sensitivity criterion derived
directly from the ROC curve. All probabilities were
two-tailed, and p-values -0.05 were regarded as sta-
tistically significant. When distinguishing between
patients with and without anemia (ns80 and ns100,
respectively) the AUC (SE) was 0.967 (0.013) using the
FER-Latex(X2)CN SEIKEN assay (95% CI, 0.929–
0.988). The AUC (SE) was comparable using the Beck-
man Immage assay: 0.979 (0.015) (95% CI, 0.926–
0.990). On the basis of the ROC curve, 40 pmol/L was
the cut-off value for anaemia at 90% sensitivity (95%
CI, 81.2–95.6) and 92% specificity (95% CI, 84.8–96.5)
for the FER-Latex(X2)CN SEIKEN assay. Using the
Beckman Immage assay, the cut-off value was
36 pmol/L at 90% sensitivity (95% CI, 82.4–96.1) and
91% specificity (95% CI, 83.9–94.5).
In conclusion, the method evaluated here can be
operated on several common automated clinical
chemistry analyzers; the new assay offers a high
degree of reproducibility, together with an extended
range, allowing direct measurement of the majority
of the samples without further external sample dilu-
tion. No statistically significant bias in linearity was
observed when samples were diluted. An analytical
and functional sensitivity of 4.5 pmol/L and impreci-
sion of CV-3% in all cases make the assay suitable
for use in the diagnosis and monitoring of iron-defi-
ciency anaemia. The wide analytical measurement
range (4.5–2471 pmol/L) is useful for patients with
tumors, inflammation or hemochromatosis. No sub-
stantial differences were observed by comparing
results of the new turbidimetric assay with the Beck-
man nephelometric assay. In addition, the calibration
curve shows good stability (1 month).
The new latex turbidimetric procedure for ferritin
assay is an attractive alternative that avoids the need
for dedicated instrumentation. Finally, this is an
example of instrument consolidation without a dete-
rioration in quality performance, an important goal
for every clinical laboratory.
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